Genomic Analysis and Lineage Identification of SARS-CoV-2 Strains in Migrants Accessing Europe Through the Libyan Route.
Mediterranean Sea
NGS
SARS-CoV-2
asylum-seeker
migrant
molecular surveillance
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
Historique:
received:
23
11
2020
accepted:
15
02
2021
entrez:
3
5
2021
pubmed:
4
5
2021
medline:
15
5
2021
Statut:
epublish
Résumé
Many African countries, representing the origin of the majority of refugees, asylum-seekers, and other migrants, toward regions bordering on the Mediterranean area, are experiencing sustained local transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Sicily is one of the main entry gates of migrants crossing into Europe. We conducted a pilot study, based on the full-genome sequencing of SARS-CoV-2 strains isolated from migrants coming to Sicily by crossing the Mediterranean Sea, with the aim to investigate the viral genome polymorphism and to describe their genetic variations and the phylogenetic relationships. On June 21, a nongovernmental organization vessel rescued 210 migrants crossing the Mediterranean Sea from Libya to Sicily. Of them, 13.4% tested positive for SARS-CoV-2. Eighteen whole genome sequences were obtained to explore viral genetic variability. All but one of the sequences clustered with other viral African strains within the lineage A, whereas only one intermixed among B.1 lineage genomes. Our findings documented that most of the investigated migrants acquired SARS-CoV-2 infection before landing in Sicily. However, SARS-CoV-2 transmission during travel or in overcrowded Libyan immigrant camps and/or illegal transport boats could not be ruled out. SARS-CoV-2 molecular surveillance on migrants arriving in Europe through the Sicilian gate may improve the knowledge of global SARS-CoV-2 transmission dynamic also in light of the emergence of new variants.
Identifiants
pubmed: 33937168
doi: 10.3389/fpubh.2021.632645
pmc: PMC8082074
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
632645Informations de copyright
Copyright © 2021 Tramuto, Reale, Lo Presti, Vitale, Pulvirenti, Rezza, Vitale, Purpari, Maida, Zichichi, Scibetta, Mazzucco and Stefanelli.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Front Microbiol. 2020 Jul 22;11:1800
pubmed: 32793182
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Wellcome Open Res. 2020 Jul 8;5:163
pubmed: 32984549
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544
pubmed: 29790989
J Community Health. 2012 Jun;37(3):547-53
pubmed: 21922163
Mol Biol Evol. 2017 Sep 1;34(9):2422-2424
pubmed: 28472384
Disaster Med Public Health Prep. 2020 Oct 19;:1-2
pubmed: 33070803
Syst Biol. 2011 Oct;60(5):685-99
pubmed: 21540409
Genome Res. 2020 Oct;30(10):1434-1448
pubmed: 32878977
Lancet. 2021 Jan 23;397(10271):267
pubmed: 33485437
Heliyon. 2020 Sep;6(9):e05001
pubmed: 32984566
Nucleic Acids Res. 2016 Jul 8;44(W1):W232-5
pubmed: 27084950
Emerg Infect Dis. 2020 Oct;26(10):2411-2415
pubmed: 32614767
J Transl Med. 2020 Apr 22;18(1):179
pubmed: 32321524
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
J Travel Med. 2021 Feb 23;28(2):
pubmed: 32946580